• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Nicholas Robert on Lag Time Between Drug Approval, Availability of the Drug in EMRs

Video

Nicholas Robert, MD, medical director of Data, Evidence & Insights, McKesson Life Sciences, discusses the lag time between a drug's approval and its availability in the electronic medical record (EMR) for the physician to order.

Nicholas Robert, MD, medical director of Data, Evidence & Insights, McKesson Life Sciences, discusses the lag time between a drug's approval and its availability in the electronic medical record (EMR) for the physician to order.

Transcript

What is the typical lag time between a drugs approval and its availability in the electronic health records with the physicians being able to order it?

One of the challenges is when there is a new regimen that’s been approved, how long is it going to take to get into the EMR, remembering that the electronic medical records is the platform for choosing your regimens. We recently looked at this and presented as a poster at ISPOR this year where we looked at NCCN and approved regimens through the National Network of Cancer Centers and we found it was on average 15 days between approval by NCCN and being incorporated into our EMR. So, physicians on average only had to wait 2 weeks for them to be able to have this new regimen, and also some of this comes with new biomarker information so we’ve done the same. We’re incorporating new biomarkers that will direct you to new treatment in the same fashion with the same sort of turnaround time.

Related Videos
Shawn Kwatra, MD, dermatologist, John Hopkins University
Dr Laura Ferris Discusses Safety, Efficacy of JNJ-2113 in Patients with Plaque Psoriasis
dr krystyn van vliet
Martin Dahl, PhD, senior vice president, AnaptysBio
Jeff Stark, MD, vice president, head of medical immunology, UCB.
Jonathan Silverberg, MD, PhD, MPH, FAAD, professor of dermatology, director of clinical research and patch testing, George Washington University School of Medicine and Health Sciences
Monica Li, MD, University of British Columbia
Robert Sidbury, MD, MPH, FAAD, professor of pediatrics, division head of dermatology, Seattle Children's Hospital, University of Washington School of Medicine
Raj Chovatiya, MD, PhD, associate professor at the Rosalind Franklin University Chicago Medical School, founder and director of the Center for Medical Dermatology and Immunology Research
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.